➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson

Last Updated: October 18, 2021

DrugPatentWatch Database Preview

Patent: 9,238,053

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

Summary for Patent: 9,238,053
Title:Methods for treatment of pain
Abstract: The invention provides for methods and compositions for treatment of pain via craniofacial mucosal administration of an analgesic compound (e.g. a non-opioid analgesic peptide, an NOP agonist or N/OFQ). Intranasal administration of certain analgesic peptides such as N/OFQ results in global analgesic effects.
Inventor(s): Toll; Lawrence R. (Redwood City, CA), Yeomans; David C. (Sunnyvale, CA), Angst; Martin S. (Palo Alto, CA), Jacobs; Daniel I. (Mountain View, CA)
Assignee: Nocicepta LLC (Wilmington, DE)
Application Number:13/802,075
Patent Claims:see list of patent claims

Details for Patent 9,238,053

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 2015-01-23 ⤷  Free Forever Trial Nocicepta LLC (Wilmington, DE) 2029-07-27 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

International Patent Family for US Patent 9,238,053

Country Patent Number Estimated Expiration
South Africa 201200584 ⤷  Free Forever Trial
World Intellectual Property Organization (WIPO) 2011017122 ⤷  Free Forever Trial
United States of America 2011021426 ⤷  Free Forever Trial
United States of America 2013196908 ⤷  Free Forever Trial
United States of America 8551949 ⤷  Free Forever Trial
Singapore 10201406930U ⤷  Free Forever Trial
>Country >Patent Number >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:


Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.